Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
+12.16%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$43.2B
AUM Growth
+$461M
(+1.1%)
Cap. Flow
-$3.42B
Cap. Flow
% of AUM
-7.91%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
2,717
New
237
Increased
842
Reduced
1,328
Closed
286
Top Buys
| 1 |
Walmart
WMT
|
+$461M |
| 2 |
Humana
HUM
|
+$343M |
| 3 |
Pfizer
PFE
|
+$292M |
| 4 |
Gilead Sciences
GILD
|
+$286M |
| 5 |
Nike
NKE
|
+$283M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$459M |
| 2 |
Merck
MRK
|
+$348M |
| 3 |
Coinbase
COIN
|
+$288M |
| 4 |
Rivian
RIVN
|
+$279M |
| 5 |
Microsoft
MSFT
|
+$277M |
Sector Composition
| 1 | Technology | 25.41% |
| 2 | Healthcare | 13.14% |
| 3 | Consumer Discretionary | 12.01% |
| 4 | Financials | 11.38% |
| 5 | Industrials | 9.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2151
American Outdoor Brands
AOUT
$106M
| $239K | ﹤0.01% |
27,200
-4,200
| -13% | -$37K |
|
2152
Gevo
GEVO
$397M
| $239K | ﹤0.01% |
311,000
-388,900
| -56% | -$299K |
|
2153
Lyell Immunopharma
LYEL
$250M
| $239K | ﹤0.01% |
5,355
+4,585
| +595% | +$204K |
|
2154
Caribou Biosciences
CRBU
$169M
| $238K | ﹤0.01% |
46,400
-22,400
| -33% | -$115K |
|
2155
Orthofix Medical
OFIX
$581M
| $238K | ﹤0.01% |
16,411
-46,500
| -74% | -$675K |
|
2156
Fortuna Silver Mines
FSM
$2.41B
| $238K | ﹤0.01% |
63,800
+50,800
| +391% | +$189K |
|
2157
Amerant Bancorp
AMTB
$895M
| $238K | ﹤0.01% |
+10,200
| New | +$238K |
|
2158
Upstart Holdings
UPST
$6.56B
| $237K | ﹤0.01% |
8,800
-221,800
| -96% | -$5.96M |
|
2159
RPC Inc
RES
$1.04B
| $236K | ﹤0.01% |
30,542
-339,000
| -92% | -$2.62M |
|
2160
EyePoint Pharmaceuticals
EYPT
$941M
| $236K | ﹤0.01% |
11,400
-12,500
| -52% | -$258K |
|
2161
Masimo
MASI
$8.08B
| $235K | ﹤0.01% |
1,600
-1,900
| -54% | -$279K |
|
2162
Omega Flex
OFLX
$351M
| $234K | ﹤0.01% |
3,300
-900
| -21% | -$63.8K |
|
2163
Patria Investments
PAX
$2.24B
| $233K | ﹤0.01% |
15,700
+1,300
| +9% | +$19.3K |
|
|
SII
2164
Sprott
SII
$1.75B
| $233K | ﹤0.01% |
6,300
-1,400
| -18% | -$51.7K |
|
2165
Ichor Holdings
ICHR
$575M
| $232K | ﹤0.01% |
6,000
-6,300
| -51% | -$243K |
|
2166
Fonar
FONR
$98.2M
| $231K | ﹤0.01% |
10,800
| – | – |
|
|
JBIO
2167
Jade Biosciences, Inc. Common Stock
JBIO
$244M
| $231K | ﹤0.01% |
+223
| New | +$231K |
|
2168
Prospect Capital
PSEC
$1.33B
| $230K | ﹤0.01% |
41,700
-300
| -0.7% | -$1.66K |
|
|
BBUC
2169
Brookfield Business Corp
BBUC
$2.43B
| $229K | ﹤0.01% |
+9,500
| New | +$229K |
|
2170
Immunic
IMUX
$81.6M
| $229K | ﹤0.01% |
173,318
+25,900
| +18% | +$34.2K |
|
2171
Adverum Biotechnologies
ADVM
$74.3M
| $229K | ﹤0.01% |
16,170
-30,060
| -65% | -$425K |
|
2172
Goodyear
GT
$2.46B
| $228K | ﹤0.01% |
16,609
-8,300
| -33% | -$114K |
|
2173
Duluth Holdings
DLTH
$145M
| $228K | ﹤0.01% |
46,500
+7,000
| +18% | +$34.3K |
|
2174
Excelerate Energy
EE
$736M
| $227K | ﹤0.01% |
14,200
+3,500
| +33% | +$56.1K |
|
2175
MainStreet Bancshares
MNSB
$170M
| $227K | ﹤0.01% |
12,500
+700
| +6% | +$12.7K |
|